Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial - Chart
- Upturn Summary
- Highlights
- Valuation
Upturn AI SWOT - About
COCH 
Envoy Medical Inc. (COCH)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- 1Y
- 1M
- 1W
Upturn Advisory Summary
11/05/2025: COCH (1-star) is currently NOT-A-BUY. Pass it for now.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Number of Analysts
4 Analysts rated it
Very few follow this stock; limited insights, higher-risk early investing.
1 Year Target Price $7.83
1 Year Target Price $7.83
| 4 | Strong Buy |
| 0 | Buy |
| 0 | Hold |
| 0 | Sell |
| 0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit -80.17% | Avg. Invested days 38 | Today’s Advisory PASS |
Upturn Star Rating | Upturn Advisory Performance  1.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 11/05/2025 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 21.04M USD | Price to earnings Ratio - | 1Y Target Price 7.83 |
Price to earnings Ratio - | 1Y Target Price 7.83 | ||
Volume (30-day avg) 4 | Beta 2.07 | 52 Weeks Range 0.70 - 2.32 | Updated Date 11/6/2025 |
52 Weeks Range 0.70 - 2.32 | Updated Date 11/6/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) -1.41 |
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin - | Operating Margin (TTM) -6500% |
Management Effectiveness
Return on Assets (TTM) -148% | Return on Equity (TTM) - |
Valuation
Trailing PE - | Forward PE - | Enterprise Value 41534436 | Price to Sales(TTM) 94.79 |
Enterprise Value 41534436 | Price to Sales(TTM) 94.79 | ||
Enterprise Value to Revenue 187.09 | Enterprise Value to EBITDA -1.35 | Shares Outstanding 28786511 | Shares Floating 13508689 |
Shares Outstanding 28786511 | Shares Floating 13508689 | ||
Percent Insiders 37.15 | Percent Institutions 44.39 |
Upturn AI SWOT
Envoy Medical Inc.
Company Overview
History and Background
Envoy Medical Inc. is a hearing health company focused on developing innovative, fully implanted medical devices. Originally developing the Esteem, Envoy Medical continues to advance technology to expand access to hearing solutions for a wider patient population.
Core Business Areas
- Fully Implanted Hearing Solutions: Envoy Medical specializes in the development, manufacture, and commercialization of fully implanted hearing devices. These devices are designed to provide natural sound quality and improved hearing experiences compared to traditional hearing aids.
Leadership and Structure
Envoy Medical is led by its CEO, and the organizational structure includes departments focused on research and development, engineering, manufacturing, sales, and marketing. Details of specific individuals and further structure can be found on the company website or investor relations materials.
Top Products and Market Share
Key Offerings
- Esteem Fully Implanted Hearing Aid: The Esteem is Envoy Medical's fully implanted hearing aid designed to provide natural sound quality and eliminate the need for external components. As a fully implantable device, Esteem directly stimulates the ossicular chain, providing natural sound quality and reducing occlusion effect. The market share is a small portion of the overall hearing aid market. Competitors are those making external hearing aids such as Sonova (SONVX) and Demant A/S (OTCQX:DMANF)
Market Dynamics
Industry Overview
The hearing aid industry is characterized by technological advancements, an aging population, and increasing awareness of hearing loss. The market is driven by demand for discreet and high-performance hearing solutions.
Positioning
Envoy Medical positions itself as an innovator in fully implanted hearing solutions, targeting individuals seeking a more natural and discreet hearing experience. Competitive advantages include its proprietary technology and fully implanted design.
Total Addressable Market (TAM)
The total addressable market for hearing aids is estimated to be billions of dollars annually. Envoy Medical is positioned to capture a segment of this market with its fully implanted solutions.
Upturn SWOT Analysis
Strengths
- Proprietary Fully Implanted Technology
- Potential for Natural Sound Quality
- Discreet Design
- Focus on Innovation
Weaknesses
- Limited Product Portfolio
- Reliance on a Niche Market
- High Product Cost
- Challenges with Reimbursement
Opportunities
- Expanding Market for Hearing Solutions
- Technological Advancements in Hearing Implants
- Partnerships with ENT Specialists
- Increased Awareness of Hearing Loss
Threats
- Competition from Established Hearing Aid Manufacturers
- Regulatory Hurdles
- Technological Disruptions
- Economic Downturns Affecting Consumer Spending
Competitors and Market Share
Key Competitors
- Sonova (SONVX)
- Demant A/S (OTCQX:DMANF)
- Cochlear Limited (CHEOY)
Competitive Landscape
Envoy Medical faces strong competition from established hearing aid manufacturers. Its competitive advantage lies in its fully implanted technology. Disadvantages include its limited product portfolio and relatively smaller market presence.
Growth Trajectory and Initiatives
Historical Growth: Historical growth can be evaluated by assessing the company's revenue and sales figures over the past few years.
Future Projections: Future projections are available through analyst estimates and company guidance. These estimates should be carefully researched and considered.
Recent Initiatives: Recent strategic initiatives could include product development, partnerships, and market expansion efforts.
Summary
Envoy Medical is a niche player focused on fully implanted hearing solutions, holding proprietary technology that is a strength. However, the company faces challenges related to market competition and the expense of their product. Future success depends on successful market penetration, managing debt and achieving profitability.
Similar Stocks
Sources and Disclaimers
Data Sources:
- SEC Filings (10-K, 10-Q)
- Company Website
- Analyst Reports
- Industry Publications
Disclaimers:
The data and analysis provided are for informational purposes only and should not be considered investment advice. Market data and analyst estimates can change over time.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Envoy Medical Inc.
Exchange NASDAQ | Headquaters White Bear Lake, MN, United States | ||
IPO Launch date 2021-04-29 | CEO & Director Mr. Brent T. Lucas Esq. | ||
Sector Healthcare | Industry Medical Devices | Full time employees 42 | Website https://www.envoymedical.com |
Full time employees 42 | Website https://www.envoymedical.com | ||
Envoy Medical, Inc., a hearing health company, focuses on providing medical technologies across the hearing loss spectrum. The company's medical technologies are designed to shift the paradigm within the hearing industry and bring providers and patients the hearing devices desire. It offers personal sound amplification devices; hearing aids; Esteem fully implanted active middle ear implants; auditory osseointegrated implants; and Acclaim cochlear implants. The company was formerly known as Envoy Medical Corporation and changed its name to Envoy Medical, Inc. in September 2023. Envoy Medical, Inc. was founded in 1995 and is headquartered in White Bear Lake, Minnesota.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.